News - UF Innovate

New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients

UF startup ViewRay, Inc., a leading medical technology company that provides groundbreaking MRI-guided radiation therapy, announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world's largest radiation oncology society.

Fighting Food Waste: Researchers Identify Broccoli Genes That Affect Freshness

As soon as a head of broccoli is harvested, an internal freshness clock starts counting down. Eventually, that crisp, green broccoli crown wilts and yellows. A study published in the journal Postharvest Biology and Technology from a team of scientists at the University of Florida, Kansas State University and Virginia Tech offers new insights into not only what makes this freshness clock tick, but also how to slow it down.

Clinical Challenges: Gene Therapy for Inherited Retinal Diseases

The FDA approval of UF's AAV technology in voretigene neparvovec (Luxturna) for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy almost 4 years ago marked a turning point in gene therapy.

Even at the Cellular Level, Ancestry Matters

In a new article published by Nature, UF professors Erika Moore, Josephine Allen, and Connie Mulligan argue it is imperative to consider ancestry in cell samples for medical research because ancestral differences are present in many diseases. Ancestry typically refers to biological or genetic characteristics, but sociocultural factors, such as language and family history, also impact ancestry. The authors argue that accounting for a person's ancestry will improve the effectiveness of treatment for patients of all backgrounds.

AI Tool Will Predict Patients at High Risk for Opioid Use Disorder and Overdose

University of Florida researchers are developing a new artificial intelligence tool that will help clinicians identify patients at high risk for opioid use disorder and overdose.

UF Develops Artificial Intelligence in ICU

A group of University of Florida Health researchers are developing an intelligent ICU, an autonomous and highly detailed patient-monitoring system driven by artificial intelligence.

Newly Discovered Coronavirus in Humans Comes From Dogs

University of Florida researchers have found that a coronavirus commonly found in dogs seems to have infected members of a medical team from the university who visited Haiti in 2017.

Too Much Iron? Pharmacosmos Is Betting $225M on a New Potential Solution for That

Pharmacosmos is putting down $225 million to purchase AbFero, a spinout from Raymond Bergeron’s lab at the University of Florida. Its lead candidate, SP-420, recently completed Phase I safety studies as a treatment for transfusional iron overload.

Pharmacosmos Group Acquires AbFero Pharmaceuticals, Inc.

Pharmacosmos Group, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, today announced the acquisition of UF startup AbFero Pharmaceuticals, Inc., a Boston-based, privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload.

Take Off in a Flying Car With UF Engineers and Alumni

As successful serial entrepreneurs, Adam Goldstein (UF BSBA ’01) and Brett Adcock (UF BSBA ’08) are always looking for the next big thing to bring to market. EVTOLs, short for electric vertical take-off-and-landing vehicles, had a compelling appeal, but there were challenges. A sector seated by large aerospace companies, staggering start-up costs and, most importantly, a new space that imposes many technology challenges, the eVTOL industry would deter any seasoned entrepreneur from entering. Yet, a chance meeting with a fellow Gator at a conference turned out to become the beginning of an adventure that could get flying taxis into the air.

UF News